Antimicrobial CMC Fibres for Uniform Wound Dressing Loading
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for incorporating antimicrobial agents like PHMB into carboxymethylcellulose (CMC) fibres for wound dressings result in uneven distribution, premature gelling, and reduced softness and conformability, leading to potential reinfection and decreased patient comfort.
Innovation Solution
A method involving submerging CMC fibres in a treatment solution containing a water-miscible organic solvent with 70% or higher organic content and 1-8% antimicrobial agent, such as PHMB, to evenly distribute the agent throughout the fibre without causing gelling, maintaining softness and flexibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antimicrobial agents are applied to textiles to provide antimicrobial protection, then the antimicrobial effectiveness is improved, but the fastness (durability) of the antimicrobial property deteriorates due to loss of substance during washing and wear
Solution Approach 1:
The patent utilizes the porous structure of chitosan fibres to entrap antimicrobial agents within the fibre matrix. The porous network provides numerous sites for physical entrapment and chemical interaction, preventing the antimicrobial agent from being easily washed away while maintaining its biological activity. This resolves the contradiction by providing both effectiveness (through sustained presence) and durability (through reduced loss).
Solution Approach 2:
The patent creates a composite material system where chitosan fibres serve as the matrix and antimicrobial agents (such as silver particles, zinc oxide, or organic antimicrobials) are incorporated within. This composite structure allows the antimicrobial agent to be physically embedded and chemically bound to the fibre, significantly reducing substance loss during washing and wear while maintaining continuous antimicrobial protection.
2Reliability
If conventional antimicrobial treatments are applied to textiles, then antimicrobial protection is achieved, but the environmental harm increases due to toxic substances leaching into the environment
Solution Approach 1:
The porous structure of chitosan fibres acts as a retention matrix that physically traps antimicrobial agents, preventing their uncontrolled release into the environment. The pore structure allows for controlled interaction with microorganisms while minimizing leaching into water systems, thus reducing environmental toxicity while maintaining protection efficacy.
Solution Approach 2:
The patent changes the physical and chemical parameters of the fibre material by using chitosan's unique properties (porosity, surface chemistry, biocompatibility) to create a system where antimicrobial agents are held in a controlled manner. This parameter change from conventional treated fibres to chitosan-based fibres reduces harmful leaching while maintaining antimicrobial activity.
3Duration of action of stationary object
If chitosan fibres are used as a carrier for antimicrobial agents, then the fastness of antimicrobial property is improved through physical entrapment, but the manufacturing complexity increases due to specialized processing requirements
Solution Approach 1:
The patent employs preliminary action by pre-forming chitosan fibres with their characteristic porous structure before incorporating the antimicrobial agents. The fibres are prepared in advance with the appropriate pore network and surface properties, then the antimicrobial agents are introduced during fibre formation or subsequent treatment steps. This preliminary preparation simplifies the overall manufacturing process compared to attempting to create the porous structure after fibre formation.
Solution Approach 2:
Chitosan fibres serve as an intermediary material between the antimicrobial agent and the final textile product. The fibres provide a biocompatible, porous matrix that facilitates the incorporation and retention of antimicrobial agents while maintaining simplicity in the overall manufacturing workflow. The intermediary chitosan structure enables straightforward integration of various antimicrobial agents without requiring complex multi-step processing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method ensures consistent antimicrobial release and improved conformability of CMC fibres, preventing reinfection by distributing the agent throughout the dressing and maintaining fibre softness, thus enhancing wound healing conditions.
Implementation Method 1
Chitosan fibres have a porous structure which can be used to physically entrap antimicrobial agents
Implementation Method 2
Chitosan fibres have a porous structure which can be used to physically entrap antimicrobial agents, or chemically interact with them
Data Source
AI summary
Described is a method of manufacturing carboxymethyl cellulose (CMC) fibres containing an antimicrobial, the fibres being suitable for use in the preparation of wound dressings, wherein the antimicrobial is selected from the group consisting of a biguanide, a biguanide derivative, octenidine, taurolidine, and a combination of two or more thereof, the method comprising, submerging CMC fibres comprising at least 95 wt% carboxymethylcellulose on a dry weight basis in a treatment solution for a duration adequate to provide the CMC fibres containing an antimicrobial, the treatment solution comprising the antimicrobial and at least 70 wt% of a water-miscible organic solvent selected from C1-C4 alkanols, C3-C5 ketones, and a combination of two or more thereof. Anti-microbial CMC fibres obtained by the methods and wound dressings containing such fibres are also described.